当前位置:首页 - 行情中心 - 兰卫医学(301060) - 财务分析 - 现金流量表

兰卫医学

(301060)

  

流通市值:38.32亿  总市值:42.62亿
流通股本:3.60亿   总股本:4.01亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金347,432,560.121,635,208,018.11,203,495,752.18781,733,754.17
  收到的税费返还-0--
  收到其他与经营活动有关的现金6,242,418.8232,165,082.7920,557,668.0612,249,793.74
  经营活动现金流入小计353,674,978.941,667,373,100.891,224,053,420.24793,983,547.91
  购买商品、接受劳务支付的现金158,403,122.54966,028,505.01719,708,529.91527,988,600.72
  支付给职工以及为职工支付的现金64,786,877.08268,481,278.48196,678,257.82135,944,398.62
  支付的各项税费7,281,317.8150,483,516.7238,582,955.3428,103,565.35
  支付其他与经营活动有关的现金21,069,757.44113,526,020.7797,324,785.8264,712,886.18
  经营活动现金流出小计251,541,074.871,398,519,320.981,052,294,528.89756,749,450.87
  经营活动产生的现金流量净额102,133,904.07268,853,779.91171,758,891.3537,234,097.04
二、投资活动产生的现金流量:
  收回投资收到的现金1,102,800,0001,907,730,0001,194,930,000748,100,000
  取得投资收益收到的现金1,751,391.864,070,899.112,851,854.991,596,141.54
  处置固定资产、无形资产和其他长期资产收回的现金净额574,8107,844,060.343,312,4702,036,417.98
  处置子公司及其他营业单位收到的现金净额27,9603,519,690.613,331,5003,331,500
  收到的其他与投资活动有关的现金-306,446.3--
  投资活动现金流入小计1,105,154,161.861,923,471,096.361,204,425,824.99755,064,059.52
  购建固定资产、无形资产和其他长期资产支付的现金3,807,905.7258,491,119.1536,112,830.5622,704,958.5
  投资支付的现金1,042,800,0001,987,564,7001,194,930,000748,100,000
  取得子公司及其他营业单位支付的现金-0--
  支付其他与投资活动有关的现金-300,000--
  投资活动现金流出小计1,046,607,905.722,046,355,819.151,231,042,830.56770,804,958.5
  投资活动产生的现金流量净额58,546,256.14-122,884,722.79-26,617,005.57-15,740,898.98
三、筹资活动产生的现金流量:
  吸收投资收到的现金-0--
  其中:子公司吸收少数股东投资收到的现金-0--
  取得借款收到的现金-50,000,00050,000,00050,000,000
  收到其他与筹资活动有关的现金-0100,000-
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-50,000,00050,100,00050,000,000
  偿还债务支付的现金9,099,857.1135,800,000110,000,00092,500,000
  分配股利、利润或偿付利息支付的现金2,274,634.18172,617,831.16157,917,270.7990,028,798.24
  其中:子公司支付给少数股东的股利、利润-79,920,00073,800,000-
  支付其他与筹资活动有关的现金2,805,046.4215,313,347.59,790,147.317,419,098.52
  筹资活动现金流出小计14,179,537.7323,731,178.66277,707,418.1189,947,896.76
  筹资活动产生的现金流量净额-14,179,537.7-273,731,178.66-227,607,418.1-139,947,896.76
四、汇率变动对现金及现金等价物的影响-1,570.96-29,451.71-27,346.41-22,973.6
五、现金及现金等价物净增加额146,499,051.55-127,791,573.25-82,492,878.73-118,477,672.3
  加:期初现金及现金等价物余额697,955,751.32825,747,324.57825,747,324.57825,747,324.57
  期末现金及现金等价物余额844,454,802.87697,955,751.32743,254,445.84707,269,652.27
补充资料:
  净利润--15,422,510.31--3,806,701.02
  资产减值准备-19,203,083.41-18,669,341.3
  固定资产和投资性房地产折旧-61,705,508-29,287,708.23
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-61,705,508-29,287,708.23
  无形资产摊销-5,012,872.24-2,508,922.77
  长期待摊费用摊销-23,872,185.49-7,129,829.73
  处置固定资产、无形资产和其他长期资产的损失-1,233,336.93-31,336.55
  固定资产报废损失-1,199,532.35-547,565.46
  公允价值变动损失--51,715.73--51,715.73
  财务费用-6,437,342.79-3,608,251.42
  投资损失--6,442,536.71-1,822,039.79
  递延所得税-14,161,336.61--170,346.64
  其中:递延所得税资产减少-16,595,891.48-753,158.36
    递延所得税负债增加--2,434,554.87--923,505
  存货的减少-32,153,737.93--28,907,838.33
  经营性应收项目的减少-117,945,290.31--28,278,756.52
  经营性应付项目的增加--5,609,418.08-28,045,934.91
  其他-936,666.67-799,587.53
  现金的期末余额-697,955,751.32-707,269,652.27
  减:现金的期初余额-825,747,324.57-825,747,324.57
  现金及现金等价物的净增加额--127,791,573.25--118,477,672.3
公告日期2026-04-292026-04-292025-10-282025-08-26
审计意见(境内)标准无保留意见
TOP↑